The week of September 29 to October 3, 2025, is set to witness multiple corporate actions, including stock splits, bonus share allotments, and dividend declarations, across prominent Indian companies.
Stock Splits
Stock splits increase the number of outstanding shares while proportionally reducing the price per share. This does not alter the total value of your investment but improves liquidity and attracts new investors.
| Company | Stock Split (Old → New) | Record Date |
| Paushak Ltd | ₹10 → ₹5 | 03-Oct-2025 |
| Sumeet Industries Ltd | ₹10 → ₹2 | 03-Oct-2025 |
Shareholders holding the stock in their demat accounts on the record date will automatically see the adjusted number of shares as per the split ratio.
Bonus Issues
Bonus shares are distributed from a company’s free reserves, increasing the number of shares held by investors without changing the total investment value.
| Company | Bonus Ratio | Record Date |
| GEE Ltd | 1:1 | 03-Oct-2025 |
| Paushak Ltd | 3:1 | 03-Oct-2025 |
| Shilpa Medicare Ltd | 1:1 | 03-Oct-2025 |
Bonus shares are credited directly to demat accounts of shareholders holding the stock as of the record date. They are issued free of cost.
Dividend Announcements
Investors can also look forward to upcoming dividend payouts.
- Glenmark Pharma – Record date: October 3, 2025
- Dividend per share: ₹2.50
Shareholders holding shares on the record date will be eligible to receive the declared dividend.
Summary
- Stock Splits: Paushak Ltd (₹10 → ₹5), Sumeet Industries Ltd (₹10 → ₹2)
- Bonus Issues: GEE Ltd (1:1), Paushak Ltd (3:1), Shilpa Medicare Ltd (1:1)
- Dividends: Glenmark Pharma – ₹2.50 per share, record date October 3, 2025
- Investor Impact: These corporate actions improve liquidity, reward shareholders, and enhance investment accessibility.
Disclaimer:
This article is intended solely for educational and informational purposes. The securities or companies mentioned are provided as examples and should not be considered as recommendations. Nothing contained herein constitutes personal financial advice or investment recommendations. Readers are advised to conduct their own research and consult a qualified financial advisor before making any investment decisions.
Investments in securities markets are subject to market risks. Please read all related documents carefully before investing.